Abortion with Sulprostone, a Prostaglandin E2 Derivative
- 1 January 1980
- journal article
- research article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 18 (1) , 40-43
- https://doi.org/10.1002/j.1879-3479.1980.tb00238.x
Abstract
Sulprostone, a prostaglandin E2 derivative, was used in a multicenter trial to terminate 478 pregnancies of 8–21 weeks' gestation. The compound was clinically well accepted without premedication in extraovular, intravenous and intramuscular routes of administration. At 24 hours after treatment, 67%–88% of the patients had aborted, with a low average incidence of side effects. Sulprostone is preferred clinically to primary prostaglandins. Intravenous infusion was found to be the safest route, but intramuscular injection proved to be the most practical.Keywords
This publication has 4 references indexed in Scilit:
- The mechanism of prostaglandin action on the early pregnant human uterusProstaglandins, 1979
- Intramuscular 16-phenoxy PGE2 ester for pregnancy terminationProstaglandins, 1979
- Pregnancy termination with the PGE2-analogue SHB 286Prostaglandins, 1978
- Termination of pregnancy with double prostaglandin impactAmerican Journal of Obstetrics and Gynecology, 1976